Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Institut Paoli Calmettes Lymphoma Database

NCT02869542

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Institut Paoli-Calmettes Marseille, Bouches-du Rhône, France

View Trial Details

Recruiting

Institut Paoli Calmettes Chronic Lymphatic Leukemia Database

NCT02869529

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations: Institut Paoli-Calmettes Marseille, Bouches-du Rhône, France

View Trial Details

Recruiting

Institut Paoli Calmettes Multiple Myeloma Database

NCT02869555

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Institut Paoli-Calmettes Marseille, Bouches-du Rhône, France

View Trial Details

Recruiting

CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas

NCT02259556

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +9 more
Locations: Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

NCT07524530

Conditions: Core Binding Factor Alpha Subunits, Hematologic Diseases, Hematologic Neoplasms, +10 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Not yet recruiting

A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)

NCT07709000

Conditions: Chronic Disease, Chronic Lymphocytic Leukaemia, Disease Attributes, +18 more
Locations: Haddasah Medical Center ( Site 0800) Jerusalem, Israel

Sheba Medical Center ( Site 0802) Ramat Gan, Israel

Sourasky Medical Center ( Site 0804) Tel Aviv, Israel

Shaare Zedek Medical Center ( Site 0801) Jerusalem, Israel

View Trial Details

Not yet recruiting

Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inhibitor or Pirtobrutinib and Previously Treated With a BCL2 Inhibitor

NCT07796373

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Not yet recruiting

Impact of Demography, Ethnicity, Co-morbidities and Inequalities on Outcomes in DLBCL Across the UKCHART Network

NCT07813585

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Not specified

View Trial Details

Not yet recruiting

Phase 1a/1b Clinical Trials to Evaluate the Safety and Preliminary Efficacy of GNTbm-38.

NCT07842445

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

Restrictive Versus Standard Antibiotic Treatment During CAR-T Therapy

NCT07842198

Conditions: Agranulocytosis, Blood Protein Disorders, Cardiovascular Diseases, +21 more
Locations: Zealand University Hospital Roskilde, Vælg Venligst Region, Denmark

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions